Obesidad en tiempos de COVID-19. Un desafío de salud global

Afshin, 2017, Health effects of overweight and obesity in 195 countries over 25 years, N Engl J Med., 377, 13, 10.1056/NEJMoa1614362 Wang, 2020, Does comorbidity increase the risk of patients with COVID-19: Evidence from meta-analysis, Aging (Albany NY)., 12, 6049, 10.18632/aging.103000 Louie, 2009, Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California, JAMA., 302, 1896, 10.1001/jama.2009.1583 Morgan, 2010, Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease, PLoS One., 5, e9694, 10.1371/journal.pone.0009694 Peng, 2020, Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV, Zhonghua Xin Xue Guan Bing Za Zhi., 48, 450 Cai, 2020, Obesity and COVID-19 severity in a designated hospital in Shenzhen, China, Diabetes Care., 43, 1392, 10.2337/dc20-0576 Garg, 2020, Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 — COVID-NET, 14 States, March 1-30, 2020, MMWR Morb Mortal Wkly Rep., 69, 458, 10.15585/mmwr.mm6915e3 Richardson, 2020, Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area, JAMA., 323, 2052, 10.1001/jama.2020.6775 Hales, 2020, Prevalence of obesity and severe obesity among adults: United States, 2017-2018, NCHS Data Brief, 360 Lighter, 2020, Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission, Clin Infect Dis., 71, 896, 10.1093/cid/ciaa415 Klang, 2020, Morbid obesity as an independent risk factor for COVID-19 mortality in hospitalized patients younger than 50, Obesity (Silver Spring)., 28, 1595, 10.1002/oby.22913 Caussy, 2020, Prevalence of obesity among adult inpatients with COVID-19 in France, Lancet Diabetes Endocrinol., 8, 562, 10.1016/S2213-8587(20)30160-1 Nie, 2014, Obesity survival paradox in pneumonia: A meta-analysis, BMC Med., 12, 61, 10.1186/1741-7015-12-61 Ni, 2017, Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis, Crit Care., 21, 36, 10.1186/s13054-017-1615-3 Petrilli, 2020, Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: Prospective cohort study, BMJ., 369, m1966, 10.1136/bmj.m1966 Hussain, 2020, Obesity and mortality of COVID-19. Meta-analysis, Obes Res Clin Pract., 14, 295, 10.1016/j.orcp.2020.07.002 Pranata, 2020, Body mass index and outcome in patients with COVID-19: A dose-response meta-analysis, Diabetes Metab., S1262-3636, 30097 Földi, 2020, Obesity is a risk factor for developing critical condition in COVID-19 patients: A systematic review and meta-analysis, Obes Rev., 21, e13095, 10.1111/obr.13095 Gold, 2020, Characteristics and clinical outcomes of adult patients hospitalized with COVID-19 — Georgia, March 2020, MMWR Morb Mortal Wkly Rep., 69, 545, 10.15585/mmwr.mm6918e1 Price-Haywood, 2020, Hospitalization and mortality among black patients and white patients with Covid-19, N Engl J Med., 382, 2534, 10.1056/NEJMsa2011686 Suleyman, 2020, Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in Metropolitan Detroit, JAMA Netw Open, 3, e2012270, 10.1001/jamanetworkopen.2020.12270 De Lusignan, 2020, Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: A cross-sectional study, Lancet Infect Dis., 20, 1034, 10.1016/S1473-3099(20)30371-6 Williamson, 2020, Factors associated with COVID-19-related death using OpenSAFELY, Nature., 584, 430, 10.1038/s41586-020-2521-4 Docherty, 2020, Features of 20 133 UK patients in hospital with Covid-19 using the ISARIC WHO Clinical Characterisation Protocol: Prospective observational cohort study, BMJ., 369, m1985, 10.1136/bmj.m1985 Bello-Chavolla, 2020, Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico, J Clin Endocrinol Metab., 105, dgaa346, 10.1210/clinem/dgaa346 McAuley, 2012, The obesity paradox, cardiorespiratory fitness, and coronary heart disease, May Clin Proc., 87, 443, 10.1016/j.mayocp.2012.01.013 Barry, 2014, Fitness vs. fatness on all-cause mortality: A meta-analysis, Prog Cardiovasc Dis., 56, 382, 10.1016/j.pcad.2013.09.002 Zbinden-Foncea, 2020, Does high cardiorespiratory fitness confer some protection against pro-inflammatory responses after infection by SARS-CoV-2?, Obesity (Silver Spring)., 28, 1378, 10.1002/oby.22849 Robinson, 2015, The relationship among obesity, nutritional status, and mortality in the critically ill, Crit Care Med., 43, 87, 10.1097/CCM.0000000000000602 Popkin, 2020, Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships, Obes Rev., 21, e13128, 10.1111/obr.13128 Informe n.° 32. Situación de COVID-19 en España a 21 de mayo de 2020. Informes COVID-19. Ministerio de Ciencia e Innovación [consultado 24 May 2020]. Disponible en: https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Paginas/InformesCOVID-19.aspx Gutiérrez-Fisac, 2012, Prevalence of general and abdominal obesity in the adult population of Spain, 2008-2010: The ENRICA study, Obes Rev., 13, 388, 10.1111/j.1467-789X.2011.00964.x Casas-Rojo, 2020, Características clínicas de los pacientes hospitalizados con COVID-19 en España: resultados del Registro SEMI-COVID-19, Rev Clin Esp., S0014-2565., 30206-X Berenguer, 2020, Characteristics and predictors of death among 4,035 consecutively hospitalized patients with COVID-19 in Spain, Clin Microbiol Infect., S1198-743X, 30431-6 Gil-Rodrigo, 2020, Evaluación de las características clínicas y evolución de pacientes con COVID-19 a partir de una serie de 1000 pacientes atendidos en servicios de urgencias españoles, Emergencias., 32, 233 Richard, 2017, Individuals with obesity and type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy, BMJ Open Diabetes Res Care., 5, e000379, 10.1136/bmjdrc-2016-000379 Dhurandhar, 2015, Interaction of obesity and infections, Obes Rev., 16, 1017, 10.1111/obr.12320 Cao, 2020, COVID-19: Immunopathology and its implications for therapy, Nat Rev Immunol., 20, 269, 10.1038/s41577-020-0308-3 Liu, 2020, Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients, EBioMedicine., 55, 102763, 10.1016/j.ebiom.2020.102763 Liu, 2020, The science underlying COVID-19: Implications for the cardiovascular system, Circulation., 142, 68, 10.1161/CIRCULATIONAHA.120.047549 Muniyappa, 2020, COVID-19 pandemic, coronaviruses, and diabetes mellitus, Am J Physiol Endocrinol Metab., 318, E736, 10.1152/ajpendo.00124.2020 Cheng, 2020, Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19, J Med Virol., 92, 726, 10.1002/jmv.25785 Ryan, 2020, Is adipose tissue a reservoir for viral spread immune activation and cytokine amplification in Coronavirus disease 2019?, Obesity (Silver Spring)., 28, 1191, 10.1002/oby.22843 Guan, 2020, Clinical characteristics of Coronavirus disease 2019 in China, N Engl J Med., 382, 1708, 10.1056/NEJMoa2002032 Stefan, 2020, Obesity and impaired metabolic health in patients with COVID-19, Nat Rev Endocrinol., 16, 341, 10.1038/s41574-020-0364-6 Sanchis-Gomar, 2020, Obesity and outcomes in COVID-19: When an epidemic and pandemic collide, Mayo Clin Proc., 95, 1445, 10.1016/j.mayocp.2020.05.006 Pereira-Santos, 2015, Obesity and vitaminD deficiency: A systematic review and meta-analysis, Obes Rev., 16, 341, 10.1111/obr.12239 Gombart, 2020, A Review of micronutrients and the immune system-working in harmony to reduce the risk of infection, Nutrients., 12, 236, 10.3390/nu12010236 Fabbri, 2020, Editorial — VitaminD status: A key modulator of innate immunity and natural defense from acute viral respiratory infections, Eur Rev Med Pharmacol Sci., 24, 4048 Shi, 2017, Chronic vitaminD deficiency induces lung fibrosis through activation of the renin-angiotensin system, Sci Rep., 7, 3312, 10.1038/s41598-017-03474-6 Martineau, 2017, VitaminD supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data, BMJ., 356, i6583, 10.1136/bmj.i6583 Quesada-Gómez, 2020, VitaminD receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166, J Steroid Biochem Mol Biol., 202, 105719, 10.1016/j.jsbmb.2020.105719 Ilie, 2020, The role of vitaminD in the prevention of coronavirus disease 2019 infection and mortality, Aging Clin Exp Res., 32, 1195, 10.1007/s40520-020-01570-8 Hastie, 2020, VitaminD concentrations and COVID-19 infection in UK Biobank, Diabetes Metab Syndr., 14, 561, 10.1016/j.dsx.2020.04.050 Ebadi, 2020, Perspective: Improving vitaminD status in the management of COVID-19, Eur J Clin Nutr., 74, 856, 10.1038/s41430-020-0661-0 Grant, 2020, Evidence that vitaminD supplementation could reduce risk of influenza and COVID-19 infections and deaths, Nutrients., 12, 988, 10.3390/nu12040988 Castillo, 2020, Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study, J Steroid Biochem Mol Biol. Dicker, 2020, Obesity and COVID-19: The two sides of the coin, Obes Facts., 10.1159/000510005 2020, Obesity-related stigma-hiding in plain sight, Lancet Diabetes Endocrinol. Lecube, 2017, Prevención, diagnóstico y tratamiento de la obesidad. Posicionamiento de la Sociedad Española para el Estudio de la Obesidad de 2016, Endocrinol Diabetes Nutr., 64, 15, 10.1016/j.endonu.2016.07.002 Luzi, 2020, Influenza and obesity: Its odd relationship and the lessons for COVID-19 pandemic, Acta Diabetol., 57, 759, 10.1007/s00592-020-01522-8 Codella, 2015, The anti-inflammatory effects of exercise in the syndromic thread of diabetes and autoimmunity, Eur Rev Med Pharmacol Sci., 19, 3709 Durrer Schutz, 2019, European practical and patient-centred guidelines for adult obesity management in primary care, Obes Facts., 12, 40, 10.1159/000496183 Rubino, 2020, Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery, Lancet Diabetes Endocrinol., 8, 640, 10.1016/S2213-8587(20)30157-1 Sánchez-Santos, 2020, Obesidad y SARS-CoV-2: Consideraciones sobre la cirugía bariátrica y recomendaciones para el inicio de la actividad quirúrgica, Cir Esp.